1. Prospective, randomised, parallel-group, open-label study to evaluate the effectiveness and safety of IMU-838, in combination with oseltamivir, in adults with COVID-19: the IONIC trial protocol. Issue 11 (17th November 2022) Authors: Sharma, Kavi; Berry, Lisa; Vryonis, Evangelos; Ali, Asad; Lara, Beatriz; Noufaily, Angela; Parsons, Nicholas; Bradley, Christopher; Haley, Becky; Tabuso, Maria; Arasaradnam, Ramesh P Journal: BMJ open Issue: Volume 12:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗